<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1376</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>1998</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>EFFEC T OF HUMAN GROWTH HORMONE TREATMEN T IN CHILDREN WI TH GROWTH HORMONE DEFICIENCY, TURNER'S SYNDROME AND ACHONDROPLASIA: A COMPARISON OF DOSE FREQUENCY AND ROU TE OF ADMINIS1RATION</title>
	<subject_fa>Pediatric</subject_fa>
	<subject>Pediatric</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Recombinant human growth hormone (hGH) was given for 6 months or longer
to 68 patients with GH deficiency, 6 with Turner's syndrome and 5 with achondroplasia,
during 1986-1994 in a prospective study.
The total weekly administered dose of GH was 0.6 u/kg. By random sampling,
29 of 68 GH deficient patients (42.6%) received twice weekly (2 iw) intramuscular
(im) injections, 17 (25%) received twice weekly subcutaneous (sc) injections and 22
received hGH 6 times per week (6 iw) sc during the first 6 months of therapy.
In the GH deficient group the mean pretreatment height velocity was 4 ± 1.2 cm!
yr (mean ±SD). The mean velocity during the first 6 months of treatment was 8.7 ±
2.3 cm/yr (p&lt;0.0005), regardless of the frequency and type of GH administration.
During the second 6 months and second year of treatment, the mean growth rates
were 7.7 ± 2.2 and 6.7 ± 2.2 cm, respectively.
The mean increase in height during the first 6 months of therapy for the 2 iw im
group (7.7 ± 1.6 cm) compared with the 2 iw sc group (7.6 ± 2.1) did not exhibit any
significant difference (0.8&lt;p&lt;0.9).
The comparison of growth velocities after 6 months of therapy using 2 i w sc (7.6
± 2.1) and 6 iw sc (10.1 ± 3.3 cm/yr) in patients with GH deficiency revealed a
statistically significant difference (p&lt;0.002).
6 patients with Turner's syndrome aged 4.5 to 15.3 years were also treated with
hGH. The mean pretreatment height velocity of 3.6 ± 0.9 cm/yr increased to 6.3 ± 0.8
cm/yr during treatment. 5 patients with achondroplasia aged 3-9.6 years also
received hGH for more than 6 months, and height velocity during GH therapy
increased compared to that before GH therapy (5.4 ± 1.4 cm/yr vs. 4.7 ± 0.9 cm/yr).
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Growth hormone deficiency, Turner\'s syndrome, Achondroplasia</keyword>
	<start_page>303</start_page>
	<end_page>306</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-331&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Z</first_name>
	<middle_name></middle_name>
	<last_name>KARAMIZADEH</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846005002</code>
	<orcid>20031947532846005002</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>From the Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>GH</first_name>
	<middle_name></middle_name>
	<last_name>AMIRHAKIMI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846005003</code>
	<orcid>20031947532846005003</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
